menu
    • menu

    Company profile for Prime Therapeutics

    NEW Drugs in Dev: 2
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Prime Therapeutics LLC (Prime) makes healthcare work better by helping people get the medicine they need to feel better and live well. Prime provides total drug management solutions for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and offers clinical services for people with complex medical conditions. Prime serves more than 30 million people. It is collectively...
    Prime Therapeutics LLC (Prime) makes healthcare work better by helping people get the medicine they need to feel better and live well. Prime provides total drug management solutions for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and offers clinical services for people with complex medical conditions. Prime serves more than 30 million people. It is collectively owned by 18 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Prime TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2900 Ames Crossing Road Eagan, MN 55121
    Telephone
    Telephone
    855.457.0007
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.primetherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Prime Saves $100M+ for Cancer & Cystic Fibrosis Patients
    Prime Saves $100M+ for Cancer & Cystic Fibrosis Patients

    10 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/prime-therapeutics-delivers-more-than-100-million-in-savings-by-improving-care-coordination-and-reducing-treatment-delays-for-cancer-and-cystic-fibrosis-patients-302708800.html

    PR NEWSWIRE
    10 Mar 2026
    Share Share
    Prime Therapeutics Names Katie Payne Chief External Affairs
    Prime Therapeutics Names Katie Payne Chief External Affairs

    13 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/prime-therapeutics-appoints-public-affairs-veteran-katie-payne-as-chief-external-affairs-officer-302613929.html

    PR NEWSWIRE
    13 Nov 2025
    Share Share
    Prime, Sempre Expand Behavior-Based Pricing for Affordability
    Prime, Sempre Expand Behavior-Based Pricing for Affordability

    30 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/prime-therapeutics-and-sempre-health-expand-innovative-behavior-based-pricing-model-to-advance-patient-affordability-302599031.html

    PR NEWSWIRE
    30 Oct 2025
    Share Share
    Emblemhealth, Prime Therapeutics Pioneer Pharmacy Benefit Collab
    Emblemhealth, Prime Therapeutics Pioneer Pharmacy Benefit Collab

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176750/0/en/EmblemHealth-and-Prime-Therapeutics-Pioneer-New-Pharmacy-Benefit-Collaboration.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Prime Shows Only 1 in 12 Stay on GLP-1 Obesity Drug After 3 Yrs
    Prime Shows Only 1 in 12 Stay on GLP-1 Obesity Drug After 3 Yrs

    25 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/prime-therapeutics-leading-research-shows-only-1-in-12-remain-on-a-glp-1-drug-for-obesity-at-three-years-302490407.html

    PR NEWSWIRE
    25 Jun 2025
    Share Share
    Prime Therapeutics showcases GLP-1 research at AMCP 2025
    Prime Therapeutics showcases GLP-1 research at AMCP 2025

    31 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/prime-therapeutics-highlights-industry-leading-glp-1-research-at-amcp-2025-302414816.html

    PR NEWSWIRE
    31 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search